A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides

Introduction. Rheumatoid arthritis (RA) patients can be classified based on presence or absence of anticitrullinated peptide antibodies (ACPA) in their serum. This heterogeneity among patients may reflect important biological differences underlying the disease process. To date, the majority of genet...

Descripción completa

Detalles Bibliográficos
Autores: Bossini Castillo, Lara, Kovel, C. de, Kallberg, H., Slot, R. van 't, Italiaander, A., Coenen, M., Tak, P. P., Posthumus, M. D., Wijmenga, Cisca, Huizinga, Tom, Helm-van Mil, A. H. M. van der, Stoeken-Rijsbergen, G., Rodríguez-Rodríguez, Luis, Balsa, Alejandro, González Álvaro, Isidoro, González-Gay, Miguel A., Gómez Vaquero, Carmen, Franke, B., LifeLines Cohort Study, Vermeulen, S., Horst-Bruinsma, I. E. van der, Dijkmans, B. A. C., Wolbink, G. J., Ophoff, Roel A., Maehlen, M. T., Riel, P. van, Merriman, M., Klareskog, L., Lie, Benedicte A., Merriman, Tony, Crusius, J. B. A., Brouwer, E., Martín, Javier, Vries, N. de, Toes, R., Padyukov, Leonid, Koeleman, Bobby P. C.
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2015
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/113070
Acceso en línea:https://hdl.handle.net/2445/113070
Access Level:acceso abierto
Palabra clave:Artritis reumatoide
Genomes
Genòmica
Anticossos monoclonals
Pèptids
Rheumatoid arthritis
Genomics
Monoclonal antibodies
Peptides
Descripción
Sumario:Introduction. Rheumatoid arthritis (RA) patients can be classified based on presence or absence of anticitrullinated peptide antibodies (ACPA) in their serum. This heterogeneity among patients may reflect important biological differences underlying the disease process. To date, the majority of genetic studies have focused on the ACPA-positive group. Therefore, our goal was to analyse the genetic risk factors that contribute to ACPA-negative RA. Methods. We performed a large-scale genome-wide association study (GWAS) in three Caucasian European cohorts comprising 1148 ACPA-negative RA patients and 6008 controls. All patients were screened using the Illumina Human Cyto-12 chip, and controls were genotyped using different genome-wide platforms. Population-independent analyses were carried out by means of logistic regression. Meta-analysis with previously published data was performed as follow-up for selected signals (reaching a total of 1922 ACPA-negative RA patients and 7087 controls). Imputation of classical HLA alleles, aminoacid residues and single nucleotide polymorphisms was undertaken. Results. The combined analysis of the studied cohorts resulted in identification of a peak of association in the HLA-region and several suggestive non-HLA associations. Meta-analysis with previous reports confirmed the association of the HLA region with this subset and an observed association in the CLYBL locus remained suggestive. The imputation and deep interrogation of the HLA region led to identification of a two aminoacid model (HLA-B at position 9 and HLA-DRB1 at position 11) that accounted for the observed genome-wide associations in this region. Conclusions. Our study shed light on the influence of the HLA region in ACPA-negative RA and identified a suggestive risk locus for this condition.

Similares en LA Referencia